Colin Pritchard, PhD, presented, "Next-generation or targeted sequencing of germline and somatic DNA in men with CRPC" at the 2017 Advanced Prostate Cancer Consensus Conference: (APCCC) in St. Gallen, Switzerland. Charles Ryan, MD, interviewed Dr. Pritchard on reading a mutation panel and what to look at and what to disregard.  Also, the classification scheme which is used by most labs and his thoughts on commercial testing options that are available and what they focus on.

Abstract by Colin Pritchard: Inherited DNA-Repair Gene Mutations in Men with Metastatic Prostate Cancer

Biographies:
Colin C. Pritchard MD, PhD is an Assistant Professor of Laboratory Medicine. He is also the associate director of the clinical molecular genetics laboratory in Laboratory Medicine at the University of Washington Medical Center, where he focuses on oncology molecular diagnostics.

Charles J. Ryan, MD

Access to all Advanced Prostate Cancer Consensus Conference Video Coverage 

Read the 2017 APCCC Report on Management of Patients with Advanced Prostate Cancer